tirzepatide administration FDA Grants a New Indication for Obesity Management Tirzepatide and Testosterone: Low T,

Landmark studies such as LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide) have shown significant reductions in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, in patients with type 2 diabetes and established cardiovascular disease or multiple risk factors

Watermelon is one of the richest fruits in glutathione

Cagrilintide is an amylin receptor agonist that some providers combine with tirzepatide for enhanced appetite suppression

Plus, more from The Bump: Uma Darji, MD, IBCLC, is a family physician and lactation consultant in Raleigh, North Carolina

Investment Strategy: Modeling MFP Contagion Effects Institutional investors and sell-side analysts should build MFP contagion scenarios into revenue models for any drug with significant Medicare exposure that is approaching its negotiation eligibility window